Furthermore, the results also suggested a three-fold higher binding activity between AGE and ApoE4 compared to binding activity between AGE and ApoE3, which signifies the pathogenic risk associated with ApoE4 in the case of fAD. The gene discussed is APOE; the disease is familial Alzheimer disease.